Thursday, October 1, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Siddhartha Devarakonda, MD

Siddhartha Devarakonda, MD

Providence Swedish Cancer Institute

Dr. Sid Devarakonda is a medical director of thoracic oncology at the Providence Swedish Cancer Institute. Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593.

Published Articles (1)

Advances in the Management of Lung Cancer in 2025 and 2026

October 1, 2026

Recent approvals in NSCLC and SCLC have advanced targeted therapies, immunotherapies, and antibody-drug conjugates across both diseases.